Study Status
Show Details
Description
Value
Participants Enrolled
1301
Sites Enrolled
176
Study Status
Active
protocol_row_id
1-1G9113
protocol_number
AA-AA-000-0000
Description
Value
Participants Enrolled
1301
Sites Enrolled
176
Study Status
Active
protocol_row_id
1-1G9113
protocol_number
AA-AA-000-0000
protocol_title
Protocol Title
nickname
Protocol Nickname
protocol_type
Investigator Sponsored
phase
P3
num_plan_site
190
num_site_actl
176
est_fpfv
2003-01-01
act_fpfv
2003-01-01
est_lplv
2021-06-01
act_lplv
2021-06-01
est_lpfv
2020-06-01
act_lpfv
2020-06-01
status
Active
num_plan_subj
1300
num_enrolled_subj_m
1301
protocol_indication
Protocol Indication
product
Product
therapeutic_area
Therapeutic Area
protocol_product_number
123
x_rbm_flg
Y
Study Overview
As of 2024-08-14, AA-AA-000-0000 has 1301 participants enrolled across
176 countries. 0 Site-KRI combinations have been flagged across 0
countries as shown in the Study Overview Table above.
0 countries have at least one red KRI
1 countries have at least one red or amber KRI
3 countries have neither red nor amber KRIS and are not shown
Results
Adverse Event Rate
Group
Enrolled
Numerator
Denominator
Metric
Score
Flag
China
257
880
199937
0
-1.19
Serious Adverse Event Rate
Group
Enrolled
Numerator
Denominator
Metric
Score
Flag
China
257
18
199937
0
-1.17
Non-Important Protocol Deviation Rate
Nothing flagged for this KRI.
Important Protocol Deviation Rate
Nothing flagged for this KRI.
Grade 3+ Lab Abnormality Rate
Nothing flagged for this KRI.
Study Discontinuation Rate
Nothing flagged for this KRI.
Treatment Discontinuation Rate
Nothing flagged for this KRI.
Query Rate
Nothing flagged for this KRI.
Outstanding Query Rate
Nothing flagged for this KRI.
Outstanding Data Entry Rate
Nothing flagged for this KRI.
Data Change Rate
Nothing flagged for this KRI.
Screen Failure Rate
Nothing flagged for this KRI.
Metric Details
File
MetricID
GroupLevel
Abbreviation
Metric
Numerator
Denominator
Model
Type
Score
Threshold
nMinDenominator
cou0001.yaml
cou0001
Country
AE
Adverse Event Rate
Adverse Events
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-2,-1,2,3
30
cou0002.yaml
cou0002
Country
SAE
Serious Adverse Event Rate
Serious Adverse Events
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-2,-1,2,3
30
cou0003.yaml
cou0003
Country
PD
Non-Important Protocol Deviation Rate
Non-Important Protocol Deviations
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-3,-2,2,3
30
cou0004.yaml
cou0004
Country
PD
Important Protocol Deviation Rate
Important Protocol Deviations
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-3,-2,2,3
30
cou0005.yaml
cou0005
Country
LB
Grade 3+ Lab Abnormality Rate
Grade 3+ Abnormal Labs Samples
Total Lab Samples
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
30
cou0006.yaml
cou0006
Country
SDSC
Study Discontinuation Rate
Subjects Discontinued - Study
Enrolled Subjects
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
3
cou0007.yaml
cou0007
Country
TDSC
Treatment Discontinuation Rate
Subjects Discontinued - Treatment
Enrolled Subjects
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
3
cou0008.yaml
cou0008
Country
QRY
Query Rate
Queries
Total Data Points
Normal Approximation
rate
Adjusted Z-Score
-3,-2,2,3
30
cou0009.yaml
cou0009
Country
OQRY
Outstanding Query Rate
Queries Open > 30 Days
Total Queries
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
30
cou0010.yaml
cou0010
Country
ODAT
Outstanding Data Entry Rate
Data Pages Entered > 10 Days
Total Data Pages
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
30
cou0011.yaml
cou0011
Country
CDAT
Data Change Rate
Data Points with 1+ Change
Total Data Points
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
30
cou0012.yaml
cou0012
Country
SF
Screen Failure Rate
Screen Failures
Screened Subjects
Normal Approximation
binary
Adjusted Z-
-3,-2,2,3
3